octreotide acetate 50 ug / mL Injection 1 mL
Comprehensive product details for sourcing and verification.
| NDC 11 | 67457-0239-01 |
|---|---|
| Product NDC | 67457-0239 |
| Generic Drug Name | octreotide acetate |
| Brand Name | Octreotide Acetate |
| Manufacturer | Mylan Institutional LLC |
| Strength | 50 ug / mL |
| Dosage Form | Injection |
| Drug Type | Intravenous; Subcutaneous |
| Package Quantity | 10 Syringe |
| Package Description | 10 SYRINGE in 1 CARTON (67457-239-01) / 1 mL in 1 SYRINGE (67457-239-00) |
| Active Ingredients | Octreotide Acetate |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
octreotide acetate 50 ug / mL Injection is tracked under NDC 67457-0239-01 and rolls up into product family 67457-0239. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 10 Syringe.
- Manufacturer: Mylan Institutional LLC.
- Dosage form: Injection.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
Public sources include public FDA and government references for octreotide acetate injection, including a 2022 FDA recall tied to a specific Mylan/Viatris lot and product/NDC records for the exact package.
Drug Shortage Index family
View Octreotide acetate in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Octreotide acetate.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
octreotide acetate 50 ug / mL Injection 1 mL, NDC 67457-0239-01, is a Mylan Institutional LLC 50 ug / mL injection presentation packaged as 10 Syringe. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 67457-0239-01.
- Digits-only NDC 11: 67457023901.
- Possible 10-digit display formats: 67457-239-01 (6745723901), 67457-0239-1 (6745702391).
Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.
Helpful product links
- Search by brand name: Octreotide Acetate.
- Exact NDC 11: 67457-0239-01.
- Product family NDC: 67457-0239.
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.